Viramune 200 mg is a medication that contains the active ingredient nevirapine, which belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). It is primarily used for the treatment of HIV-1 infection in combination with other antiretroviral medications.
Dosage and Administration:
The dosage of Viramune 200 mg may vary depending on individual factors such as the patient’s weight, medical history, and other medications they are taking. It is crucial to follow the prescribed dosage provided by your healthcare provider. The recommended initial dose for most adult patients is as follows:
- Week 1: Take one 200 mg tablet of Viramune once daily.
- Week 2: Take one 200 mg tablet of Viramune twice daily, approximately every 12 hours.
After the initial two-week period, the maintenance dose is usually increased to two 200 mg tablets (400 mg total) taken once daily or as directed by your healthcare provider. The tablets should be swallowed whole with water and can be taken with or without food. It is important to take the medication consistently and not miss any doses to maintain its effectiveness.
If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.
It is important to note that Viramune 200 mg should always be used in combination with other HIV medications as part of a comprehensive treatment regimen. Your healthcare provider will determine the appropriate combination therapy for your specific condition.
Possible Side Effects:
Like any medication, Viramune 200 mg can cause side effects. Common side effects may include rash, fever, headache, fatigue, nausea, vomiting, and liver abnormalities. It is crucial to report any adverse effects to your healthcare provider, as some side effects may require medical attention.
Serious but rare side effects of Viramune include severe skin reactions (such as Stevens-Johnson syndrome), liver toxicity, and hypersensitivity reactions. If you experience any signs of a severe allergic reaction (e.g., rash, itching, swelling, dizziness, difficulty breathing), seek immediate medical attention.
Precautions:
Before starting Viramune 200 mg, inform your healthcare provider about your medical history, including any liver problems, allergies, or other ongoing medical conditions. It is important to disclose all medications, including prescription, over-the-counter drugs, and supplements, as they may interact with Viramune.
Viramune is contraindicated in patients with moderate to severe liver impairment. Your healthcare provider will assess your liver function before initiating treatment and may monitor it during therapy.
Pregnant individuals or those planning to become pregnant should inform their healthcare provider, as Viramune use during pregnancy may require special precautions.
In summary, Viramune 200 mg is an NNRTI medication used in combination with other antiretroviral drugs for the treatment of HIV-1 infection. The dosage and treatment plan will be determined by your healthcare provider based on various factors. It is important to take Viramune consistently, as prescribed, and report any side effects or concerns to your healthcare provider.